Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 987-994

  Wu, Ping ^a   Zhang, Hua ^a   Qi, Lin ^a   Tang, Qingping ^b   Tang, Yaoyun ^a   Xie, Zhihai ^a   Lv, Yunxia ^a   Zhao, Suping ^a   Jiang, Weihong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Department of Rehabilitation   (China)

Author keywords

ERp29; Human nasopharyngeal carcinoma; Proteomics; Radioresistance

Indexed keywords

BIOLOGICAL MARKER; ENDOPLASMIC RETICULUM PROTEIN 29; HEAT SHOCK PROTEIN 27; MANGANESE SUPEROXIDE DISMUTASE; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RADIOSENSITIVITY; TREATMENT RESPONSE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHINA; COMPUTATIONAL BIOLOGY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FLOW CYTOMETRY; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROTEOMICS; RADIATION TOLERANCE; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84863012852     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1586     Document Type: Article

References (35)

1. Yu MC and Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12: 421-429, 2002. (Pubitemid 35370755)
2. Chow E, Payne D, O'Sullivan B, Pintilie M, Liu FF, Waldron J, Warde P and Cummings B: Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiother Oncol 63: 269-274, 2002. (Pubitemid 34874554)
3. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V and Fu KK: Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53: 12-22, 2002. (Pubitemid 34465802)
4. Leung SF, Teo PM, Shiu WW, Tsao SY and Leung TW: Clinical features and management of distant metastases of nasopharyngeal carcinoma. J Otolaryngol 20: 27-29, 1991.
5. Huang H, Pan XH, Zhou JH, Yu L, Kong XT, Zhou SM, Li ZJ, Fu Q and Sun XY: The effect of Epstein-Barr virus gene BHRF1 expression on radioresistance of nasopharyngeal carcinoma cells. ORL J Otorhinolaryngol Relat Spec 60: 329-333, 1998. (Pubitemid 28464323)
6. Qu Y, Zhao S, Hong J and Tang S: Radiosensitive gene therapy through imRNA expression for silencing manganese superoxide dismutase. J Cancer Res Clin Oncol 136: 953-959, 2010.
7. Feng XP, Yi H, Li MY, Li XH, Yi B, Zhang PF, Li C, Peng F, Tang CE, Li JL, Chen ZC and Xiao ZQ: Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res 70: 3450-3462, 2010.
8. Ruan L, Wang GL, Yi H, Chen Y, Tang CE, Zhang PF, Li MY, Li C, Peng F, Li JL, Chen ZC and Xiao ZQ: Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. J Cell Biochem 110: 975-981, 2010.
9. Reymond MA and Schlegel W: Proteomics in cancer. Adv Clin Chem 44: 103-142, 2007.
10. Hubbard MJ: Functional proteomics: The goalposts are moving.Proteomics 2: 1069-1078, 2002.
11. Van Anken E, Romijn EP, Maggioni C, Mezghrani A, Sitia R, Braakman I and Heck AJ: Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion. Immunity 18: 243-253, 2003. (Pubitemid 36262999)
12. Baryshev M, Sargsyan E, Wallin G, Lejnieks A, Furudate S, Hishinuma A and Mkrtchian S: Unfolded protein response is involved in the pathology of human congenital hypothyroid goiter and rat non-goitrous congenital hypothyroidism. J Mol Endocrinol 32: 903-920, 2004. (Pubitemid 38877693)
13. Li D, Sun F and Wang K: Caloric restriction retards age-related changes in rat retina. Biochem Biophys Res Commun 318: 253-258, 2003.
14. Myung JK, Afjehi-Sadat L, Felizardo-Cabatic M, Slavc I and Lubec G: Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci 2: 8, 2004.
15. Cheretis C, Dietrich F, Chatzistamou I, Politi K, Angelidou E, Kiaris H, Mkrtchian S and Koutselini H: Expression of ERp29, an endoplasmic reticulum secretion factor in basal-cell carcinoma. Am J Dermatopathol 28: 410-412, 2006. (Pubitemid 44511190)
16. Shnyder SD, Mangum JE and Hubbard MJ: Triplex profiling of functionally distinct chaperones (ERp29/PDI/BiP) reveals marked heterogeneity of the endoplasmic reticulum proteome in cancer. J Proteome Res 7: 3364-3372, 2008.
17. Zhang B, Wang M, Yang Y, Wang Y, Pang X, Su Y, Wang J, Ai G and Zou Z: ERp29 is a radiation-responsive gene in IEC-6 cell. Radiat Res 49: 587-596, 2008.
18. To EW, Chan KC, Leung SF, Chan LY, To KF, Chan AT, Johnson PJ and Lo YM: Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin Cancer Res 9: 3254-3259, 2003. (Pubitemid 37082718)
19. Shanmugaratnam K and Sobin LH: The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 71: 2689-2697, 1993. (Pubitemid 23100513)
20. Cheng AL, Huang WG, Chen ZC, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Peng F, Duan CJ and Xiao ZQ: Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res: 7: 2415-2426, 2008.
21. Hara A and Okayasu I: Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 108: 43-48, 2004. (Pubitemid 38961072)
22. Latterich M, Abramovitz M and Leyland-Jones B: Proteomics: new technologies and clinical applications. Eur J Cancer 44: 2737-2741, 2008.
23. Hubbard MJ, McHugh NJ and Carne DL: Isolation of ERp29, a novel endoplasmic reticulum protein, from rat enamel cells evidence for a unique role in secretory protein synthesis. Eur J Biochem 267: 1945-1957, 2000.
24. Mkrtchian S, Baryshev M, Matvijenko O, Sharipo A, Sandalova T, Schneider G and Ingelman-Sundberg M: Oligomerization properties of ERp29, an endoplasmic reticulum stress protein. FEBS Lett 431: 322-326, 1998. (Pubitemid 28352383)
25. Hung YC, Wang PW, Pan TL, Bazylak G and Leu YL: Proteomic screening of antioxidant effects exhibited by radix Salvia milti- orrhiza aqueous extract in cultured rat aortic smooth muscle cells under homocysteine treatment. J Ethnopharmacol 124: 463-474, 2009.
26. Dukes AA, Van Laar VS, Cascio M and Hastings TG: Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine. J Neurochem 106: 333-346, 2008. (Pubitemid 351840216)
27. Harding HP, Calfon M, Urano F, Novoa I and Ron D: Tran- scriptional and translational control in the Mammalian unfolded protein response. Annu Rev Cell Dev Biol 18: 575-599, 2002. (Pubitemid 35387362)
28. Sidrauski C, Chapman R and Walter P: The unfolded protein response: An intracellular signaling pathway with many surprising features. Trends Cell Biol 8: 245-249, 1998. (Pubitemid 28243207)
29. Rutkowski DT and Kaufman RJ: A trip to the ER: Coping with stress. Trends Cell Biol 14: 20-28, 2004. (Pubitemid 38076857)
30. Zhang D and Putti TC: Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells. Exp Cell Res 316: 3522-3531, 2010.
31. Matsumoto M, Minami M, Takeda K, Sakao Y and Akira S: Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett 395: 143-147, 1996. (Pubitemid 26356172)
32. McCullough KD, Martindale JL, Klotz LO, Aw T and Holbrook NJ: Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bc1-2 and perturbing the cellular redox state. Mol Cell Biol 21: 1249-1259, 2001. (Pubitemid 32114973)
33. Hadchity E, Aloy MT, Paulin C, Armandy E, Watkin E, Rousson R, Gleave M, Chapet O and Rodriguez-Lafrasse C: Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma. Mol Ther 17: 1387-1394, 2009.
34. Aloy MT, Hadchity E, Bionda C, Diaz-Latoud C, Claude L, Rousson R, Arrigo AP and Rodriguez-Lafrasse C: Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells. Int J Radiat Oncol Biol Phys 70: 543-553, 2008.
35. Maliutina IaV and Kabakov AE: Preirradiation heat shock protein induction increases cellular radioresistance. Radiats Biol Radioecol 47: 273-279, 2007 (In Russian).